Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPersimmon Regulatory News (PSN)

Share Price Information for Persimmon (PSN)

Share Price is delayed by 15 minutes
Get Live Data
1,078.50    26.00 (2.47%)
Bid:
1,071.00
Ask:
1,072.00
Spread: 1.00 (0.093%)
Market Cap: £3.46b
PSN Live PriceLast checked at - London Stock Exchange

Intraday Persimmon Share Chart

Interim Management Statement

22 Apr 2010 07:00

RNS Number : 5867K
Persimmon PLC
22 April 2010
 



INTERIM MANAGEMENT STATEMENT

THURSDAY 22 APRIL 2010

 

 

 

Persimmon plc is holding its Annual General Meeting at 12 noon today at York Racecourse where the following comments will be made regarding current trading, financial performance and the outlook for the financial year. This statement, which supplements the update given at the time of our 2009 results, covers the period from 1 January 2010 to the date of this announcement and constitutes Persimmon Plc's first Interim Management Statement in 2010.

 

Since we announced our results for the year ended 31 December 2009 on 2 March 2010 weekly sales volumes have remained consistent despite a backdrop of continued uncertainty regarding the wider economic outlook and the forthcoming General Election. Total sales, including legal completions to date, are c. 20% ahead of last year at c. £1.15 billion. Sales volumes are c. 11% ahead including a higher content of private sales and prices remain firm. Encouragingly, weekly visitors per site are constant with good conversion to reservations. Cancellation rates remain at historically low levels.

 

Maintaining an appropriate level of sales while focusing on achieving price growth in all regions continues to form the basis of our current strategy. Margin improvement remains a priority.

 

We are opening new developments in line with our planned investment programme while closely monitoring working capital levels across the business. We are currently operating from c. 375 sites having opened 50 new sites through the first quarter of the year in line with our expectations. We have a further 40 sites which we currently intend to start during the second quarter. These new site openings will provide us with the opportunity to secure some further price improvement and maintain sales momentum.

 

We continue to focus on minimising build costs and on the strict control of overhead costs.

 

Against this background of trading we are carefully selecting land opportunities for investment. Whilst we continue to apply strict criteria to land purchases, we have recently acquired some excellent sites including some from our strategic land portfolio upon which we have now received residential planning consents. This new land will generate higher margins as development commences during the next 12 months.

 

At the end of March, the point in the financial year where we approach our traditional peak seasonal working capital requirements, net borrowings were at c. £265 million (31 March 2009: £680 million). Debt levels are expected to reduce further as the year progresses.

 

With margin improvement underway, cash generation remaining robust, and our high quality consented and strategic landbanks, we are in a strong position in the UK housing market to deliver profitable growth.

 

We will give a further update on trading on Tuesday 6 July 2010 following the half year end.

 

For further information, please contact:

 

 

M:Communications

Edward Orlebar

Tel: +44 (0) 7738 724 630

Charlotte McMullen

Tel: +44 (0) 207 920 2349

Marylène Guernier

Tel: +44 (0) 7776 303 788

 

Persimmon plc

Mike Farley, Group Chief Executive

Mike Killoran, Group Finance Director

Tel: +44 (0) 1904 642199

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSUAVNRROASUAR
Date   Source Headline
7th Nov 20197:00 amRNSThird Quarter Trading Statement
1st Nov 201912:18 pmRNSTotal Voting Rights
21st Oct 20193:09 pmRNSBoard Changes
17th Oct 20192:39 pmRNSDirector/PDMR Shareholding
15th Oct 201911:19 amRNSAdditional Listing
1st Oct 20192:37 pmRNSTotal Voting Rights
20th Aug 20198:41 amRNSHalf-year results - Amendment
20th Aug 20197:00 amRNSHalf-year Results
1st Aug 20195:40 pmRNSTotal Voting Rights
4th Jul 20197:00 amRNSTrading Update
11th Jun 20197:18 amRNSDirector/PDMR Shareholding
3rd Jun 20191:53 pmRNSBlock listing Interim Review
3rd Jun 20191:48 pmRNSTotal Voting Rights
23rd May 20191:07 pmRNSAdditional Listing
1st May 20194:22 pmRNSResult of AGM
1st May 201911:23 amRNSTotal Voting Rights
1st May 20197:00 amRNSTrading Update
17th Apr 20197:00 amRNSDirector Appointment
1st Apr 20191:42 pmRNSTotal Voting Rights
21st Mar 20197:00 amRNSCustomer Care Improvement Plan
18th Mar 20192:30 pmRNSAnnual Financial Report
12th Mar 20193:19 pmRNSAdditional Listing
4th Mar 20191:36 pmRNSDirector/PDMR Shareholding
1st Mar 20194:34 pmRNSTotal Voting Rights
26th Feb 20197:00 amRNSCEO Appointment
26th Feb 20197:00 amRNSFinal Results
1st Feb 20194:36 pmRNSTotal Voting Rights
15th Jan 20197:00 amRNSTrading Update
11th Jan 20195:55 pmRNSHolding(s) in Company
2nd Jan 201912:55 pmRNSTotal Voting Rights
11th Dec 201810:18 amRNSDirector/PDMR Shareholding
7th Dec 201812:04 pmRNSDirector/PDMR Shareholding
6th Dec 20184:53 pmRNSDirector/PDMR Shareholding
4th Dec 20183:25 pmRNSBlock listing Interim Review
3rd Dec 20183:50 pmRNSTotal Voting Rights
7th Nov 20187:00 amRNSCEO change
7th Nov 20187:00 amRNSThird Quarter Trading Statement
1st Nov 20184:35 pmRNSTotal Voting Rights
24th Oct 20185:39 pmRNSAdditional Listing
23rd Oct 20185:57 pmRNSEBT Share Purchase
19th Oct 20189:47 amRNSDirector/PDMR Shareholding
15th Oct 20184:08 pmRNSEBT Share Purchase
8th Oct 20184:36 pmRNSHolding(s) in Company
3rd Oct 20183:52 pmRNSEBT Share Purchase
1st Oct 20182:20 pmRNSTotal Voting Rights
19th Sep 201810:31 amRNSEBT Share Purchase
3rd Sep 201810:36 amRNSTotal Voting Rights
21st Aug 20187:00 amRNSHalf Year Results
1st Aug 20181:44 pmRNSTotal Voting Rights
5th Jul 20187:00 amRNSTrading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.